Betamethasone

CHEMBL632 Phase 4 Одобрено Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
392.5 g/mol
LogP
1.9
Phase
4

A potent synthetic corticosteroid that reduces inflammation and suppresses the immune system, used to treat a wide range of conditions including severe allergies, skin disorders, and inflammatory diseases. It is available in many formulations including creams, injections, and tablets. Long-term use carries risks of adrenal suppression and other systemic effects.

Молекулярная масса

392,5000 g/mol

LogP

1,90

TPSA

94,80 Ų

Правило пяти Липинского

Соответствует

Терапевтические области

Механизм действия

Binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene transcription. This suppresses multiple inflammatory genes encoding cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory proteins.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Механизм

Binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene transcription. This suppresses multiple inflammatory genes encoding cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory proteins.

2D Структура

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO

InChI

InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1

Molecular Formula

C22H29FO5

HBD / HBA

3 / 6

Вращаемые Связи

2

Тяжёлые Атомы

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

A potent synthetic corticosteroid that reduces inflammation and suppresses the immune system, used to treat a wide range of conditions including severe allergies, skin disorders, and inflammatory diseases. It is available in many formulations including creams, injections, and tablets. Long-term use carries risks of adrenal suppression and other systemic effects.

Binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene transcription. This suppresses multiple inflammatory genes encoding cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory proteins.

Yes, Betamethasone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL632. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9782. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.